MGMA yields 2000000.00% · JNJ yields 2.13%● Live data
📍 MGMA pulled ahead of the other in Year 1
Combined, MGMA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MGMA + JNJ for your $10,000?
Metro Global Media, Inc. operates through its wholly owned subsidiaries and operating divisions: Metro West Studios, Inc.; Metro, Inc. - West Coast Division; Metro International Distributors; Amazing Media Group, Inc.; Amazing Direct, Inc.; Metro, Inc. East Coast Division; and Airborne for Men, LTD. Through Metro Studios, Metro Global produces and distributes erotic motion picture entertainment. Metro West, the company's West Coast division, duplicates, manufactures, warehouses, and distributes exclusively all of Metro Studio's productions on Vertical Helical Scan and Digital Versatile Disc formats. Metro International operates an international sales office in Flensburg, Germany to handle the sales of video rights in Europe, South America, and Australia. Amazing Media publishes and distributes a variety of adult magazines under various trade names. AmazingDirect.com is the company's e-commerce and mail order business. Airborne engages in the sale of franchise and licensing rights to operate upscale adult orientated retail stores. The company was incorporated in 1987 and is based in Cranston, Rhode Island.
Full MGMA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.